Isfahan University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Frequency of Myasthenia Gravis in Multiple Sclerosis: Report of Five Cases From Isfahan, Iran Publisher Pubmed



Basiri K1 ; Etemadifar M1 ; Maghzi AH1 ; Zarghami N1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Neurology, Isfahan University of Medical Sciences, Alzahra Hospital, Isfahan, Sofe Ave, Iran

Source: Neurology India Published:2009


Abstract

This study was designed to determine the frequency and clinical characteristics of myasthenia gravis (MG) in a large cohort of Persian patients with multiple sclerosis (MS) living in the province of Isfahan. We reviewed the case records of patients with definite MS (McDonald's criteria) registered in the Isfahan MS Society (IMSS) for associated MG. Of the 1,718 patients with MS in the registry, six patients were found to have both MS and MG. The prevalence after excluding one patient with insufficient data, was 291 per 100,000 (0.29%), a higher prevalence than the earlier reports. These results may support the hypothesis that MS and MG share some common immunopathogenic mechanisms.
Related Docs
View other Related Docs
1. Myasthenia Gravis During the Course of Neuromyelitis Optica, Case Reports in Neurology (2011)
2. Myasthenia Gravis and Covid-19: A Systematic Review and Meta-Analysis, Basic and Clinical Neuroscience (2024)
3. Multiple Sclerosis in Isfahan, Iran, International Review of Neurobiology (2007)
4. Epidemiology of Multiple Sclerosis in Iran: A Systematic Review, European Neurology (2013)
5. Prevalence and Incidence of Multiple Sclerosis in Isfahan, Iran Between 1996 and 2021: A Population-Based Study, Multiple Sclerosis and Related Disorders (2024)
6. Estimated Prevalence and Incidence of Multiple Sclerosis in Iran, European Neurology (2014)
7. Sharp Increase in the Incidence and Prevalence of Multiple Sclerosis in Isfahan, Iran, Multiple Sclerosis Journal (2011)
8. Is Myasthenia Gravis a Real Complication of the Covid-19 Vaccine? a Case Report-Based Systematic Review, Canadian Journal of Infectious Diseases and Medical Microbiology (2022)
Experts (# of related papers)
View all Related Experts
Masoud Etemadifar (38)
Vahid Shaygannejad (29)
Other Related Docs
9. Mannose-Binding Lectin Mediated Complement Pathway in Autoimmune Neurological Disorders, Iranian Journal of Allergy, Asthma and Immunology (2016)
10. Ongoing Increase in Incidence and Prevalence of Multiple Sclerosis in South-Eastern Iran: A Three Decade Study, Multiple Sclerosis and Related Disorders (2023)
11. Prevalence of Multiple Sclerosis in Isfahan, Iran, Neuroepidemiology (2006)
12. Epidemiology of Familial Multiple Sclerosis in Iran: A National Registry-Based Study, BMC Neurology (2022)
13. Effect of Mediterranean Diet on Body Mass Index and Fatigue Severity in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis of Clinical Trials, Heliyon (2024)
14. Prevalence of Hypothyroidism Among Patients With Multiple Sclerosis Referred to Multiple Sclerosis Clinic of Alzahra Hospital, Isfahan, Iran, During 2014-2015, Journal of Isfahan Medical School (2016)
15. Serum Mercury Level and Multiple Sclerosis, Biological Trace Element Research (2012)
16. Outcome of Covid-19 Infection in Multiple Sclerosis Patients Receiving Disease-Modifying Therapies, Journal of Research in Medical Sciences (2021)
17. Prognostic Value of Intrathecal Igg Synthesis in Multiple Sclerosis: A Study in 54 Patients, Tehran University Medical Journal (2008)
18. Prescription Trends of Disease-Modifying Treatments for Multiple Sclerosis in Iran Over the Past 30 Years, Multiple Sclerosis and Related Disorders (2022)
19. Prevalence of Familial Multiple Sclerosis in Isfahan, Iran, Journal of Isfahan Medical School (2011)
20. Multiple Sclerosis: Pathophysiology, Clinical Features, Diagnosis, and Management, Neuroinflammation (2011)
21. The Global Prevalence of Familial Multiple Sclerosis: An Updated Systematic Review and Meta-Analysis, BMC Neurology (2021)
22. Prevalence of Multiple Sclerosis (Ms) in Iran: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
23. Comparing the Frequency of Tim-3 Polymorphism in Multiple Sclerosis Patients With Healthy Controls, Journal of Isfahan Medical School (2015)
24. Safety of Sinopharm Vaccine for People With Multiple Sclerosis: Study of Adverse Reactions and Disease Activity, Multiple Sclerosis and Related Disorders (2022)
25. Consanguineous Marriage Among Familial Multiple Sclerosis Subjects: A National Registry-Based Study, Heliyon (2024)
26. Late-Onset Multiple Sclerosis in Iran: A Report on Demographic and Disease Characteristics, Multiple Sclerosis and Related Disorders (2023)
27. Co-Occurrence of Multiple Sclerosis and Thomsen’S Myotonia: A Report of Two Cases, Functional Neurology (2014)
28. Interferon-Beta in Pediatric Multiple Sclerosis Patients: Safety in Short-Term Prescription, Acta Medica Iranica (2012)
29. Side Effects of Methylprednisolone Pulse Therapy in Treatment of Multiple Sclerosis, Journal of Isfahan Medical School (2012)
30. Higher Latitude Is Significantly Associated With an Earlier Age of Disease Onset in Multiple Sclerosis, Journal of Neurology, Neurosurgery and Psychiatry (2016)
31. Pure Spinal Multiple Sclerosis: A Case Series of a Possible New Entity, Journal of Neuroimmunology (2025)
32. Cytomegalovirus Seroposivity in Iranian Multiple Sclerosis: A Randomized Case-Control Study, Pakistan Journal of Medical Sciences (2012)
33. Multiple Sclerosis Relapse After Covid-19 Vaccination: A Case Report-Based Systematic Review, Journal of Clinical Neuroscience (2022)
34. Increased Proportion of Tc17 and Th17 Cells and Their Significant Reduction After Thymectomy May Be Related to Disease Progression in Myasthenia Gravis, NeuroImmunoModulation (2018)
35. Time Interval Between the Onset of Symptoms and Diagnosis of Multiple Sclerosis and the Influential Factors: A National Registry-Based Study, Clinical Neurology and Neurosurgery (2024)
36. Stress Differentially Predicts Multiple Sclerosis Relapses, Neurology Asia (2014)
37. Association of Helicobacter Pylori With Multiple Sclerosis: Protective or Risk Factor?, Current Journal of Neurology (2020)
38. Clinical and Epidemiological Aspects of Multiple Sclerosis in Children, Iranian Journal of Child Neurology (2017)
39. Prevalence of Dysphagia in Patients With Multiple Sclerosis: A Systematic Review and Meta-Analysis, Journal of Clinical Neuroscience (2023)
40. Myasthenia Gravis and Coronavirus Disease 2019: A Report From Iran, Current Journal of Neurology (2021)
41. The Frequency of Tim-3-1541C>T Polymorphisms and Its Association With Multiple Sclerosis, Journal of Isfahan Medical School (2015)
42. Does Early-Onset Multiple Sclerosis Differ From Adult-Onset Form in Iranian People, Journal of Research in Medical Sciences (2010)
43. The Association of Multiple Sclerosis With Thyroid Disease: A Meta-Analysis, Multiple Sclerosis and Related Disorders (2023)
44. Prevalence and Risk Factors of Dysphagia in Patients With Multiple Sclerosis, Dysphagia (2022)
45. Multiple Sclerosis Epidemiology in Asia and Oceania; a Systematic Review and Meta-Analysis, Multiple Sclerosis and Related Disorders (2021)
46. Covid-19 Vaccines and Patients With Multiple Sclerosis: Willingness, Unwillingness and Hesitancy: A Systematic Review and Meta-Analysis, Neurological Sciences (2022)
47. Epidemiological and Clinical Features of Pediatric-Onset Multiple Sclerosis: A Population-Based Study in Isfahan, Iran, Between 1997-2020, Current Journal of Neurology (2021)
48. Estimated Incidence Rate of Multiple Sclerosis and Its Relationship With Geographical Factors in Isfahan Province Between the Years 2001 and 2014, International Journal of Preventive Medicine (2018)
49. A Novel Approach to Discriminate Subgroups in Multiple Sclerosis, Iranian Journal of Allergy, Asthma and Immunology (2016)
50. Efficacy and Safety of Rituximab in Multiple Sclerosis: A Systematic Review and Meta-Analysis, Acta Neurologica Belgica (2023)